{
    "nctId": "NCT01609920",
    "briefTitle": "Nodal Staging in Breast Cancer With MRL",
    "officialTitle": "Non-invasive Nodal Staging in Breast Cancer With Magnetic Resonance Imaging Lymphography Using Gadofosveset",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 97,
    "primaryOutcomeMeasure": "The diagnostic performance (sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV)) of axillary MRL in predicting the involvement of metastases",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patient with histopathologically confirmed breast cancer about to undergo nodal staging.\n2. Willing and able to undergo all study procedures\n3. Has personally provided written informed consent.\n\nExclusion Criteria:\n\n1. Age \\<18,\n2. Pregnancy\n3. Contra indications for MRL such as pacemaker, aneurysm clips or severe claustrophobia.\n4. Allergy to any of the ingredients of Gadofosveset (Vasovist\u00ae /Ablavar\u00ae)\n5. Being unable to give informed consent in person\n6. Acute or chronic severe renal insufficiency (glomerular filtration rate \\<45 mL/min/1.73m2)1.\n7. Acute renal insufficiency of any severity due to the hepato-renal syndrome.\n8. Known (or suspicion of) QT- prolongation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}